Publications by authors named "Angela Zupa"

Claim this Profile
Mutant Allele Frequency in Melanoma and its Correlation With Clinicopathological Characteristics.
Angela Zupa, Giulia Vita, Ludmila Carmen Omer, Giovanni Calice, Raffele Conca

Anticancer Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Exon 19 Insertions: Do Patients Respond to Tyrosine Kinase Inhibitor Treatment?
Giuseppina Improta, Giulia Vita, Alfredo Tartarone, Giovanni Calice, Ludmila Carmen Omer, Angela Zupa

Anticancer Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine.
Elisa Baldelli, K Alex Hodge, Guido Bellezza, Neil J Shah, Guido Gambara, Angela Zupa

J Immunother Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Epigenetic Eight-Gene Signature Predictive of Poor Prognosis and MSI-Like Phenotype in Human Metastatic Colorectal Carcinomas.
Valentina Condelli, Giovanni Calice, Alessandra Cassano, Michele Basso, Maria Grazia Rodriquenz, Angela Zupa

Cancers (Basel)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncommon frame-shift exon 19 EGFR mutations are sensitive to EGFR tyrosine kinase inhibitors in non-small cell lung carcinoma.
Giuseppina Improta, Angela Zupa, Maria Iole Natalicchio, Lorenza Sisinni, Anna Marinaccio

Med Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients.
Antonio Nappi, Rosj Gallicchio, Vittorio Simeon, Anna Nardelli, Alessandra Pelagalli, Angela Zupa

Radiol Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrosequencing evaluation of low-frequency KRAS mutant alleles for EGF receptor therapy selection in metastatic colorectal carcinoma.
Maria Iole Natalicchio, Giuseppina Improta, Angela Zupa, Olga Elisabetta Cursio, Emanuela Stampone

Future Oncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of resistance to EGFR tyrosine kinase inhibitors gefitinib/erlotinib and to ALK inhibitor crizotinib.
Alfredo Tartarone, Chiara Lazzari, Rosa Lerose, Vincenza Conteduca, Giuseppina Improta, Angela Zupa

Lung Cancer· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coexistence of two different mutations in codon 12 of the Kras gene in colorectal cancer: Report of a case supporting the concept of tumoral heterogeneity.
Giuseppina Improta, Angela Zupa, Luciana Possidente, Alfredo Tartarone, Piernicola Pedicini

Oncol Lett· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of preeclampsia-related angiogenic factors in sunitinib cardiotoxicity: two cases and review of the literature.
Giuseppina Gallucci, Alfredo Tartarone, Carlo Gabriele Tocchetti, Anna Maria Bochicchio, Mariarosa Coccaro, Angela Zupa

Future Oncol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a new insertion in exon 20 of EGFR in a woman with NSCLC.
Angela Zupa, Giulia Vita, Matteo Landriscina, Luciana Possidente, Michele Aieta

Med Oncol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot characterization of human lung NSCLC by protein pathway activation mapping.
Angela Zupa, Giuseppina Improta, Alessandra Silvestri, Elisa Pin, Jianghong Deng

J Thorac Oncol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein pathway activation mapping of brain metastasis from lung and breast cancers reveals organ type specific drug target activation.
Giuseppina Improta, Angela Zupa, Helen Fillmore, Jianghong Deng, Michele Aieta

J Proteome Res· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphisms of the CYP1A1, CYP2E1 and XRCC1 genes and cancer risk in a Southern Italian population: a case-control study.
Gabriella Bianchino, Achille Cittadini, Vitina Grieco, Antonio Traficante, Angela Zupa

Anticancer Res· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk: a case-control study.
Angela Zupa, Alessandro Sgambato, Gabriella Bianchino, Giuseppina Improta, Vitina Grieco

Anticancer Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.
Giuseppina Improta, Alessandro Sgambato, Gabriella Bianchino, Angela Zupa, Vitina Grieco

Anticancer Res· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glutathione S-transferase (GST) polymorphisms as risk factors for cancer in a highly homogeneous population from southern Italy.
Alessandro Sgambato, Biagina Campisi, Angela Zupa, Annamaria Bochicchio, Gianpiero Romano

Anticancer Res· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis